Phase 1 Study of the Pittsburgh Compound B Derivative <sup>18</sup>F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease - Concepedia

Concepedia

Publication | Open Access

Phase 1 Study of the Pittsburgh Compound B Derivative <sup>18</sup>F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease

DOI Full Paper Access

338

Citations

37

References

2009

Year

Natalie Nelissen, Koen Van Laere, Lennart Thurfjell, Rikard Owenius, Mathieu Vandenbulcke, Michel Koole, Guy Bormans, David J. Brooks, Rik Vandenberghe

Journal of Nuclear Medicine

Abstract

(18)F-flutemetamol uptake can be readily quantified. This phase 1 study warrants further studies to validate this (18)F-labeled derivative of PiB as a biomarker for Abeta amyloidosis.

References

	Year	Citations

Page 1